Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
TransCode Therapeutics Stock (NASDAQ: RNAZ) stock price, news, charts, stock research, profile.
Open | $0.29 |
Close | $0.27 |
Volume / Avg. | 309.75K / 1.06M |
Day Range | $0.27 - $0.29 |
52 Wk Range | 0.22 - 128.00 |
Market Cap | $4.68M |
P/E Ratio | 0.00 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 33 |
Short Interest | 9.48% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of TransCode Therapeutics (NASDAQ:RNAZ) through any online brokerage.
Other companies in TransCode Therapeutics’s space includes: Virios Therapeutics (NASDAQ:VIRI), Tharimmune (NASDAQ:THAR), Synaptogenix (NASDAQ:SNPX), Palisade Bio (NASDAQ:PALI) and Trevena (NASDAQ:TRVN).
TransCode Therapeutics has a consensus price target of $3.00.
The stock price for TransCode Therapeutics (NASDAQ: RNAZ) is $0.271 last updated August 23, 2024 at 7:46 PM EDT.
There are no upcoming dividends for TransCode Therapeutics.
TransCode Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for TransCode Therapeutics.
TransCode Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.